AKT antibody and kinase pathway reagents: choose in matched pairs

Designing a kinase experiment

1. Buy phospho and total together, always. The two reagents must be raised for the same protein and used on the same sample, ideally the same membrane through fluorescent multiplexing. A phospho signal without its total is uninterpretable.
2. Name the site. Kinases carry several regulatory phosphorylation sites that report different things, including activation, inhibition and priming. A reagent described only as phospho is not a specification.
3. Put phosphatase inhibitors in first. Phosphorylation is stripped within minutes in a cold lysate. Inhibitors go into the buffer before the cells meet it, and the path from plate to denatured sample must be short and rehearsed.
4. Time course before single timepoint. Kinase activation peaks in minutes. One time course per cell type and stimulus establishes where the peak is, and every subsequent single timepoint is chosen from that curve.
5. Use an inhibitor as the specificity control. A selective inhibitor of the kinase should collapse the phospho signal without changing the total. That pair of lanes is stronger evidence than any datasheet.
6. Treat small GTPases as activity assays. Nucleotide bound state, not abundance, is what matters for these proteins, and it is measured by pull down with an effector domain rather than by a blot of total protein.

Pairs, sites and inhibitors

Three habits separate reliable kinase work from the rest: reagents bought in phospho and total pairs, sites named in the methods, and a selective inhibitor lane included as the specificity control. None of them is expensive and together they remove most of the criticism this class of figure attracts.

Fluorescent multiplexing makes the pair trivial, because both can be read from the same membrane without stripping.

Cascades are read at two points, not one

Measuring one node tells you little about flux through a cascade, because feedback and parallel inputs are everywhere. Choosing one proximal and one distal node, and a late negative regulator, describes the response far better.

Where the conclusion is about pathway activity rather than one protein, that three point picture is what makes it defensible.

A mapk antibody, and which member of the family it actually detects

The mitogen activated kinases share a catalytic fold and a phosphorylation motif, so a mapk antibody sold under the family name may report several of them at once. Read the immunogen: a clone raised against a conserved activation loop will light up p38 and JNK beside ERK. Where the experiment is about one member, the datasheet has to name the isoform and show a knockdown or a single band at the expected mass.

A tbk1 antibody is read as a phosphorylation, not as a level

TBK1 protein does not move much when the innate sensing pathway fires; what moves is serine 172 on the kinase and the downstream phosphorylation of IRF3. So a tbk1 antibody is bought as a pair with a phospho specific clone and run on the same membrane, and a stimulation that shows no change in total protein is the expected result rather than a failed blot. Phosphatase inhibitors go in before the cells are scraped.

A gsk3b antibody and the inhibitory serine that carries the meaning

This kinase is constitutively active and is switched off by phosphorylation of serine 9, which inverts the usual reading: more phospho signal means less enzyme activity. A gsk3b antibody for total protein is the denominator, and the phospho clone against that residue is the measurement. Antibodies against the alpha and beta forms cross react often enough that the datasheet has to state which it was raised on and what it was tested against.

A phospho erk antibody beside the total blot it needs

Phospho ERK rises and falls within minutes, so the harvest time is part of the reagent choice. A phospho erk antibody detects the doubly phosphorylated threonine and tyrosine in the activation loop and should be read against total ERK on the same lysate, because a rise in ratio is the claim and a rise in signal alone is not. Two bands at forty two and forty four kilodaltons are ERK2 and ERK1.

A p-akt antibody, and the total blot it means nothing without

Serine 473 and threonine 308 are phosphorylated by different kinases and answer different questions, so a p-akt antibody has to name its residue and the figure has to say which was measured. The total antibody on the same membrane is what turns a band into a ratio. Growth factor stimulation over a short series is the positive control, and a phosphatase inhibitor cocktail is what keeps the signal alive.

A pi3k antibody names a subunit, never the pathway

There is no single PI3K protein to stain. A pi3k antibody is raised against one catalytic or regulatory subunit, most often p110 alpha or p85, and the choice decides what the blot means. Since the pathway is usually read downstream through phosphorylated AKT and S6, a subunit antibody is for expression and knockdown validation rather than for activity. The datasheet should state the subunit, the species tested and the expected mass.

A shp2 antibody on a phosphatase read through its partners

SHP2 abundance rarely changes, so a shp2 antibody is used to confirm expression, to validate a knockdown and to pull the protein down, while the activity question is answered by the phosphorylation of ERK downstream or by phosphotyrosine on a named partner. Clones differ in whether they see the closed autoinhibited conformation, which matters for immunoprecipitation, so the datasheet has to say the application it was validated in.

A jak1 antibody and the family cross reactivity to rule out

JAK1, JAK2 and TYK2 run close together above one hundred kilodaltons and share kinase domain sequence, which is how a family cross reacting clone produces a convincing band on the wrong protein. A jak1 antibody should carry a knockout or knockdown lane in its validation data, and the cytokine stimulation that phosphorylates the receptor is the control that says the pathway, not just the protein, was detected.

Common questions

Why did my phospho signal disappear?

Handling, in most cases: missing phosphatase inhibitor, warm buffer, or too long between the dish and denaturation. Fix the lysis protocol before suspecting the reagent.

Which phosphorylation site should I measure?

The one whose regulation your hypothesis concerns, named explicitly. Different sites on the same kinase report activation, inhibition and priming, and reporting phospho without a site is not a result.

Can total kinase level from an AKT antibody substitute for activity?

No. Expression and activity are independent, and treatments commonly change one without the other. Where activity is the claim, measure phosphorylation at a defined site or run an activity assay.

Browse by service class

• Compare Gene synthesis on advertised prices